A E Ross|D R McKenzie - JoVE Visualize

Showing results (81-90 of 95) with videos related to

Pageof 10

Sort By:

Physical Review Letters|June 9, 2018

Graphitization of Glassy Carbon after Compression at Room TemperatureT B Shiell, D G McCulloch, D R McKenzie, et al.

The American Journal of Medicine|July 1, 1995

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reactionJ L Goodman, J F Bradley, A E Ross, et al.

Prostate Cancer and Prostatic Diseases|May 4, 2016

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesS P Rowe, M A Gorin, M E Allaf, et al.

International Journal of Impotence Research|October 14, 2011

Increased expression of nestin in the major pelvic ganglion following cavernous nerve injuryO Kutlu, A E Ross, E M Schaeffer, et al.

Medical Oncology (Northwood, London, England)|June 12, 2020

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.

Prostate Cancer and Prostatic Diseases|November 6, 2013

Very-high-risk localized prostate cancer: definition and outcomesD Sundi, V M Wang, P M Pierorazio, et al.

Prostate Cancer and Prostatic Diseases|April 19, 2017

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillanceJ J Tosoian, H D Patel, M Mamawala, et al.

Prostate Cancer and Prostatic Diseases|January 4, 2017

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, et al.

Prostate Cancer and Prostatic Diseases|January 25, 2017

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.

Prostate Cancer and Prostatic Diseases|October 23, 2013

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.

Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:

Pageof 10

Physical Review Letters|June 9, 2018

Graphitization of Glassy Carbon after Compression at Room TemperatureT B Shiell, D G McCulloch, D R McKenzie, et al.

The American Journal of Medicine|July 1, 1995

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reactionJ L Goodman, J F Bradley, A E Ross, et al.

Prostate Cancer and Prostatic Diseases|May 4, 2016

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesS P Rowe, M A Gorin, M E Allaf, et al.

International Journal of Impotence Research|October 14, 2011

Increased expression of nestin in the major pelvic ganglion following cavernous nerve injuryO Kutlu, A E Ross, E M Schaeffer, et al.

Medical Oncology (Northwood, London, England)|June 12, 2020

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.

Prostate Cancer and Prostatic Diseases|November 6, 2013

Very-high-risk localized prostate cancer: definition and outcomesD Sundi, V M Wang, P M Pierorazio, et al.

Prostate Cancer and Prostatic Diseases|April 19, 2017

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillanceJ J Tosoian, H D Patel, M Mamawala, et al.

Prostate Cancer and Prostatic Diseases|January 4, 2017

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, et al.

Prostate Cancer and Prostatic Diseases|January 25, 2017

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.

Prostate Cancer and Prostatic Diseases|October 23, 2013

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.

Pageof 10